Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.
Press releases published on September 18, 2025
IMMERSIVE LIVE MUSIC EXPERIENCE ‘LUMINISCENCE’ TO MAKE U.S. DEBUT AFTER SOLD-OUT EUROPEAN RUN
After Selling Nearly One Million Tickets in Europe in Just Under Two Years, LUMINISCENCE Premieres in Minneapolis on Oct. 31 MINNEAPOLIS, MN, UNITED STATES, September 18, 2025 /EINPresswire.com/ -- After captivating nearly one million spectators in …
Vertical Insure Partners with GrowthZone to Offer Registration Protection for Associations, Chambers, and Their Members
Partnership helps associations increase registrations, protect event revenue, and simplify refunds for attendees. MINNEAPOLIS, MN, UNITED STATES, September 18, 2025 /EINPresswire.com/ -- Vertical Insure, an embedded insurance platform, has partnered …
QCI’s Andrew Cardno to Speak on Optimizing Casino Floor Mix at Global Gaming Expo 2025
SAN DIEGO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in AI-driven casino analytics, announced today that Co-Founder and Chief Technology Officer Andrew Cardno will be a featured speaker at the Global Gaming Expo ( …
ServiceTitan to Empower HVAC Contractors with Acquisition of Conduit Tech
LOS ANGELES, Sept. 18, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (Nasdaq: TTAN), the software platform that powers the trades, today announced that it has entered into a definitive agreement to acquire Conduit Tech, an HVAC design and sales platform that …
Nutanix Welcomes Greg Lavender to Board of Directors
SAN JOSE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, announced today that it has added Greg Lavender to its board of directors, effective September 17, 2025. “Greg has a deep engineering …
KatalisCoin Addresses Market Confusion in Indonesia, Launches Proactive User Protection Initiative
DENVER, CO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- KatalisCoin CRYPTO GROUP LIMITED, a U.S.-registered global digital asset exchange, today announced the launch of a comprehensive User Protection Initiative for the Indonesian market. The program is designed to …
Union.ai Introduces Flyte 2.0 to Power Dynamic, Fault-Tolerant, Resource-Aware AI Workflows
BELLEVUE, Wash., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Union.ai, the leader in AI orchestration, recently unveiled Flyte 2.0, the next generation of the open-source orchestration engine designed for modern AI, ML, and agentic workloads. Flyte 2.0 introduces a …
Cologix Expands Investment in Toronto with Acquisition of CIM Group’s interest in TOR4 and Strategic Facility Acquisition of CIM Group’s 105 Clegg Data Center
DENVER and TORONTO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cologix, a leading network-neutral interconnection and hyperscale edge data center company in North America, today announced it has acquired full ownership of TOR4, a purpose-built hyperscale data …
Cologix accroît son investissement à Toronto avec l'acquisition de la participation du CIM Group dans TOR4 et l’acquisition d’une installation stratégique de CIM Group au centre de donnés du 105 Clegg
DENVER et TORONTO, 18 sept. 2025 (GLOBE NEWSWIRE) -- Cologix, le chef de file nord-américain d’interconnexions neutres et des centres de données hyperscale edge, a annoncé aujourd’hui avoir acquis la pleine propriété de TOR4, un centre de données …
DBV Technologies Announces Resignation of Board Member
Châtillon, France, September 18, 2025 DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical company, today announced …
DBV Technologies annonce la démission d’un membre de son Conseil d’administration
Châtillon, France, le 18 septembre 2025 DBV Technologies annonce la démission d’un membre de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la “Société” ou “DBV”), une société biopharmaceutique au …
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
EMERYVILLE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company”) previously announced a one-time special cash dividend of $0.80 per share for the Company’s common stock. The special cash dividend …
DIH Holding US, Inc. Receives Additional Nasdaq Staff Determination Letter
DIH Receives Notice of Additional Basis for Delisting from The Nasdaq Stock Market DIH Has Requested Hearing to Appeal before Nasdaq Hearing Panel NORWELL, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI …
Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
REDWOOD CITY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell …
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
CUPERTINO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of …
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Carlsbad, CA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients living with autoimmune, inflammatory, …
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 966,000 shares of its common stock, consisting …